Combined with Apria’s existing infusion patient base, the new infusion division, which will remain headquartered in Denver, Colorado, is expected to care for more than 100,000 patients annually and is licensed to serve patients in all 50 states.
Commenting on the acquisition, Lawrence Higby, Apria’s CEO, said: “Strategically, it transforms the company by diversifying our product and payor mix and positioning us favorably in the rapidly growing specialty pharmaceutical and infusion markets. From a customer perspective, we believe it offers a number of expanded clinical and integrated homecare solutions to patients, physicians and payors alike. Now that the transaction is complete, we will begin implementing our integration plans, and look forward to realizing the strategic and financial synergies that this transaction creates for Apria in 2008 and beyond.”